113 results on '"Cazzola, Mario"'
Search Results
2. Dual bronchodilation for the treatment of COPD: From bench to bedside
3. Classification of myeloid neoplasms/acute leukemia: Global perspectives and the international consensus classification approach
4. PD‐L1 overexpression correlates withJAK2 ‐V617Fmutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms
5. Long‐acting muscarinic antagonists and small airways in asthma: Which link?
6. Impaired virus‐specific T cell responses in patients with myeloproliferative neoplasms treated with ruxolitinib
7. Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: Synergy of triple combination therapy on human airway smooth muscle ex vivo
8. Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases
9. Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes
10. Impact of bone marrow fibrosis grade in post‐polycythemia vera and post‐essential thrombocythemia myelofibrosis: A study of the MYSEC group
11. Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients
12. Ruxolitinib treatment and risk of B‐cell lymphomas in myeloproliferative neoplasms
13. Pregnancy outcome and management of 25 pregnancies in women with polycythemia vera
14. Advances in understanding the pathogenesis of familial myeloproliferative neoplasms
15. Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms
16. The effect of arterial hypertension on thrombosis in low‐risk polycythemia vera
17. Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients
18. Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group
19. Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphoma
20. Successful treatment with Rituximab and Bendamustine in a patient with newly diagnosed Waldenström's Macroglobulinemia complicated by Bing‐Neel syndrome
21. Common germline variation at the TERT locus contributes to familial clustering of myeloproliferative neoplasms
22. Bone marrow assessment in asymptomatic immunoglobulin M monoclonal gammopathies
23. A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera
24. Pregnancy complications predict thrombotic events in young women with essential thrombocythemia
25. A novel germlineJAK2mutation in familial myeloproliferative neoplasms
26. Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome
27. A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea
28. Monoclonal gammopathy of undetermined significance: a new proposal of workup
29. Correlation between burden of 17P13.1 alteration and rapid escape to plasma cell leukaemia in multiple myeloma
30. Effects of mitochondrial ferritin overexpression in normal and sideroblastic erythroid progenitors
31. Good clinical activity and favorable toxicity profile of once weekly bortezomib, fotemustine, and dexamethasone (B‐MuD) for the treatment of relapsed multiple myeloma
32. Chronic lymphocytic leukemia with del13q14 as the sole abnormality: dynamic prognostic estimate by interphase-FISH
33. Clinical significance of genetic aberrations in secondary acute myeloid leukemia
34. Unraveling the genetic underpinnings of myeloproliferative neoplasms and understanding their effect on disease course and response to therapy: Proceedings from the 6th international post-ASH symposium
35. Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies
36. Response-adjusted ISS (RaISS) is a simple and reliable prognostic scoring system for predicting progression-free survival in transplanted patients with multiple myeloma
37. Identification of genomic aberrations associated with disease transformation by means of high‐resolution SNP array analysis in patients with myeloproliferative neoplasm
38. Iron overload and iron chelation therapy in patients with myelodysplastic syndrome treated by allogeneic stem-cell transplantation: Report from the working conference on iron chelation of the Gruppo Italiano Trapianto di Midollo Osseo
39. Epithelium integrity is crucial for the relaxant activity of brain natriuretic peptide in human isolated bronchi
40. Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome
41. β2-adrenoceptor agonists: current and future direction
42. The relevance of transfusion-dependency in the prognostic assessment of patients with myeloid neoplasms
43. correspondence: Incidence of leukaemia in patients with primary myelofibrosis and RBC-transfusion-dependence
44. Gene expression profiling of erythroblasts from refractory anaemia with ring sideroblasts (RARS) and effects of G-CSF
45. Blast phase of essential thrombocythemia: A single center study
46. Marked downregulation of the granulopoiesis regulatorLEF1is associated with disease progression in the myelodysplastic syndromes
47. Cold Haemagglutinin Disease with Severe Anaemia, Reticulocytopenia and Erythroid Bone Marrow
48. Prognostic relevance of anemia in myelodysplastic syndromes
49. General Pharmacological Considerations in Antibiotic Treatment of Community‐Acquired Pneumonia
50. Iron loading in congenital dyserythropoietic anaemias and congenital sideroblastic anaemias
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.